Guggenheim Strategic Opportunities Fund 8-K Filing
Ticker: GOF · Form: 8-K · Filed: Nov 25, 2025 · CIK: 1380936
| Field | Detail |
|---|---|
| Company | Guggenheim Strategic Opportunities Fund (GOF) |
| Form Type | 8-K |
| Filed Date | Nov 25, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $1,000,000,000 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Guggenheim Strategic Opportunities Fund (ticker: GOF) to the SEC on Nov 25, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (Common Shares of Beneficial Interest , $0.01 par value GOF New York Stock Exchan); $1,000,000,000 (gregate initial offering price of up to $1,000,000,000, from time to time, through Cantor Fitz).
How long is this filing?
Guggenheim Strategic Opportunities Fund's 8-K filing is 2 pages with approximately 728 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 728 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2025-11-24 17:52:51
Key Financial Figures
- $0.01 — Common Shares of Beneficial Interest , $0.01 par value GOF New York Stock Exchan
- $1,000,000,000 — gregate initial offering price of up to $1,000,000,000, from time to time, through Cantor Fitz
Filing Documents
- gugg89409-8k.htm (8-K) — 28KB
- exhibit11.htm (EX-99) — 13KB
- 0001821268-25-000255.txt ( ) — 213KB
- gof-20251124.xsd (EX-101.SCH) — 3KB
- gof-20251124_def.xml (EX-101.DEF) — 3KB
- gof-20251124_lab.xml (EX-101.LAB) — 2KB
- gof-20251124_pre.xml (EX-101.PRE) — 5KB
- gugg89409-8k_htm.xml (XML) — 4KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. Guggenheim Strategic Opportunities Fund (NYSE: GOF) (the "Fund") has entered into a Controlled Equity Offering SM Sales Agreement, dated July 1, 2019, as amended by First Amendment to Controlled Equity Offering SM Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering SM Sales Agreement, dated September 16, 2021, Third Amendment to Controlled Equity Offering SM Sales Agreement, dated March 27, 2023, Fourth Amendment to Controlled Equity Offering SM Sales Agreement, dated May 3, 2024, and Fifth Amendment to Controlled Equity Offering SM Sales Agreement, dated November 21, 2025 (as amended, the "Sales Agreement"), by and among the Fund, Guggenheim Funds Investment Advisors, LLC, and Cantor Fitzgerald & Co. ("Cantor Fitzgerald") relating to the Fund's common shares of beneficial interest, par value $0.01 per share (the "Common Shares"). In accordance with the terms of the Sales Agreement, the Fund may offer and sell Common Shares having an aggregate initial offering price of up to $1,000,000,000, from time to time, through Cantor Fitzgerald as agent for the Fund for the offer and sale of the Common Shares (the "Offering"). The Offering has been made pursuant to a prospectus supplement, dated November 21, 2025, and the accompanying prospectus, dated November 21, 2025, as supplemented from time to time, each of which constitute part of the Fund's effective shelf registration statement on Form N-2 (File No. 333-291739) previously filed with the Securities and Exchange Commission (the "Registration Statement"). The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement, which is in part incorporated by reference to the Registration Statement and in part filed with this report as Exhibit 1.1 and incorporated herein by reference.
01. Other Events
Item 8.01. Other Events. On November 24, 2025, the Fund commenced the Offering pursuant to the Registration Statement. The Fund incorporates by reference the exhibit filed herewith into the Registration Statement.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits 1.1 Fifth Amendment to Controlled Equity Offering SM Sales Agreement, dated November 21, 2025, by and among the Fund, Guggenheim Funds Investment Advisors, LLC, and Cantor Fitzgerald & Co.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUGGENHEIM STRATEGIC OPPORTUNITIES FUND Date: November 24, 2025 By: /s/ Mark E. Mathiasen Name: Mark E. Mathiasen Title: Secretary